Literature DB >> 9552959

Ethics and evidence based medicine.

I Kerridge, M Lowe, D Henry.   

Abstract

Keywords:  Health Care and Public Health

Mesh：

Year:  1998        PMID： 9552959      PMCID： PMC1112944          DOI： 10.1136/bmj.316.7138.1151

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  24 in total

1.  Getting to grips with Archie Cochrane's agenda.

Authors:  I Chalmers; K Dickersin; T C Chalmers
Journal:  BMJ       Date:  1992-10-03

2.  Of mice but not men. Problems of the randomized clinical trial.

Authors:  S Hellman; D S Hellman
Journal:  N Engl J Med       Date:  1991-05-30       Impact factor: 91.245

3.  Ethical issues and clinical trials.

Authors:  D S Shimm; R G Spece
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

4.  Nazi science--the Dachau hypothermia experiments.

Authors:  R L Berger
Journal:  N Engl J Med       Date:  1990-05-17       Impact factor: 91.245

5.  The Nazi hypothermia experiments and unethical research today.

Authors:  M Angell
Journal:  N Engl J Med       Date:  1990-05-17       Impact factor: 91.245

6.  Users' guides to the medical literature. II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group.

Authors:  G H Guyatt; D L Sackett; D J Cook
Journal:  JAMA       Date:  1994-01-05       Impact factor: 56.272

7.  Evidence-based care: 1. Setting priorities: how important is the problem? Evidence-Based Care Resource Group.

Authors: 
Journal:  CMAJ       Date:  1994-04-15       Impact factor: 8.262

8.  Rationale for systematic reviews.

Authors:  C D Mulrow
Journal:  BMJ       Date:  1994-09-03

9.  Why do we need some large, simple randomized trials?

Authors:  S Yusuf; R Collins; R Peto
Journal:  Stat Med       Date:  1984 Oct-Dec       Impact factor: 2.373

10.  GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.

Authors: 
Journal:  Lancet       Date:  1990-07-14       Impact factor: 79.321
View more
  18 in total

1.  The price of autonomy.

Authors:  Michael Baum; Jayant S. Vaidya
Journal:  Health Expect       Date:  1999-05       Impact factor: 3.377

Review 2.  Criteria for evaluating evidence on public health interventions.

Authors:  L Rychetnik; M Frommer; P Hawe; A Shiell
Journal:  J Epidemiol Community Health       Date:  2002-02       Impact factor: 3.710

3.  Whither our art? Clinical wisdom and evidence-based medicine.

Authors:  Malcolm Parker
Journal:  Med Health Care Philos       Date:  2002

Review 4.  Ethical problems arising in evidence based complementary and alternative medicine.

Authors:  E Ernst; M H Cohen; J Stone
Journal:  J Med Ethics       Date:  2004-04       Impact factor: 2.903

Review 5.  Explanatory models are needed to integrate RCT and observational data with the patient's unique biology.

Authors:  Vijay Sharma; Rubin Minhas
Journal:  J R Soc Med       Date:  2012-01       Impact factor: 5.344

6.  The limits of evidence: evidence based policy and the removal of gamete donor anonymity in the UK.

Authors:  Lucy Frith
Journal:  Monash Bioeth Rev       Date:  2015-03

7.  Ethics and Epistemology of Big Data.

Authors:  Wendy Lipworth; Paul H Mason; Ian Kerridge
Journal:  J Bioeth Inq       Date:  2017-11-08       Impact factor: 1.352

8.  Clinical relevance of the gap between pre-marketing trials and medical practice: the case of the cardiovascular drugs.

Authors:  N F Wieringa; P Denig; P A de Graeff; R Vos
Journal:  Neth Heart J       Date:  2002-11       Impact factor: 2.380

9.  Why general practitioners do not implement evidence: qualitative study.

Authors:  A C Freeman; K Sweeney
Journal:  BMJ       Date:  2001-11-10

10.  Evidence-based medicine: the fourth revolution in American medicine?

Authors:  Kevin C Chung; Ashwin N Ram
Journal:  Plast Reconstr Surg       Date:  2009-01       Impact factor: 4.730
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.